Background: The cell population data (CPD) measured by Sysmex XN-9000 can be used for screening many hematological and non-hematological disorders. Since little information is available on harmonization of CPD among different instrumentation and clinical laboratories, this study aimed at assessing the current degree of CPD harmonization between separate Sysmex XN modules allocated to the same laboratory. Methods: A total number of 78291 data were used for verification of within-run imprecision, analyzers harmonization, reference ranges and assessment of blood sample stability of CPD parameters, including results of daily quality control testing and those generated in samples collected from blood donors and healthy volunteers. Results: Within-run imprecision of CPD parameters ranged between 0.4 and 14.1%. Good agreement was found among five different XN-modules, especially when values were adjusted after calculation of instrument-specific alignment factors. The bias of all parameters remained always
Introduction
The development of innovative technologies and analytical principles in flow cytometry has been accompanied by commercialization of a new generation of hematological analyzers (HA) capable of generating both quantitative (i.e., cell counts and cellular indices) and qualitative (e.g., morphological flags, scattergrams) information, which also have a high degree of analytical efficiency for identifying many cellular abnormalities (1) (2) (3) . The cell population data (CPD) measured by HA reflect some morphological parameters of white blood cell (WBC) subpopulations, and can be used for screening many hematological and non-hematological disorders. The Sysmex XN-9000 (Sysmex Kobe Japan) not only measures conventional hematologic parameters, but can also generate innovative WBC parameters such as high fluorescence lymphocytes cell (HFLC) and CPD. The analytical techniques are essentially based on fluorescence flow cytometry for WBC differential count, and on a combination of forward scatter (FSC), side scatter (SSC) and fluorescence intensity (SFL) for detecting different WBC populations, respectively. These three measurements, together with their relative distribution width (W), can then be combined for obtaining CPD of neutrophils (NE), lymphocytes (LY) and monocytes (MO) populations.
Recent studies showed that NE CPD parameters (i.e., NE-SSC, NE-SFL) may be useful for diagnosing myelodysplastic syndromes and sepsis, whilst NE-SFL and MO-WX may play a role in differential diagnosis of some acute leukemias (4) (5) (6) (7) (8) (9) . Some LY CPD param eters (i.e., LY-X, LY-Y and LY-Z) may then provide valuable information for screening lymphoproliferative diseases (10, 11) . Nevertheless, little information is available on the analytical quality specification of CPD, and even less is known on the degree of harmonization of these measures among different instrumentation and clinical laboratories. This last aspect is especially important due to the worldwide reorganization of laboratory diagnostics, which increasingly encompasses the shipment of blood specimens from one laboratory to another, thus potentially jeopardizing sample quality (12) . Therefore, the aim of this study was to assess the current degree of CPD harmonization between separate Sysmex XN modules installed in the same laboratory.
Materials and Methods

Description of the XN-module hematological analyzer
The XN-9000 is the largest core model belonging to the XN-Series, being composed by up to seven separate analytical modules. A typical combination entails three »green« analyzers allocated for CBC and DIFF profiles, two »blue« analyzers allocated for App-RET, App PLT-F and App WPC analysis, along with a single slide preparation unit (Autoslider SP-10; Sysmex Co., Kobe, Japan) integrated with a slide processing system (DI60; Sysmex Co., Kobe, Japan). The analysis of all samples included in this study was carried out according to manufacturer's instructions. The quality of data was validated by routine use of internal quality controls, based on three different levels of proprietary materials.
lower than the reference change values in samples stored for up to 8 hours, regardless of storage temperature. Conclusions: The imprecision of CPD parameters was acceptable, except for those reflecting the dispersion of cellular clusters. Due to the lack of reference control materials, we showed that the use of data generated on a large number of normal routine samples (i.e., a Moving Average population) may be a reliable approach for testing analyzers harmonization. Nevertheless, availability of both calibration and quality control materials for these parameters is highly advisable in the future. We finally showed that whole blood samples may be stable for up to 2-4 hours for most CPD parameters.
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Within-run imprecision of cell population data
Five blood samples collected in K 3 EDTA tubes (Becton Dickinson, NJ) from a single healthy volunteer (the inclusion criteria were based on negative clinical history and normal serum concentrations of glucose, creatinine, aminotransferases, ferritin and C reactive protein) were preliminary mixed, and five identical aliquots were then produced. Within-run imprecision of CPD parameters was assessed by performing 10 consecutive measures of the five aliquots, as recommended by the Clinical and Laboratory Standards Institute (CLSI) document EP05-A3 (13) . All aliquots were then analyzed in all the five separate XN-modules with a specific protocol, as follows: in the first round the samples were analyzed from module 1 to 5, in the second round from module 2 to 1, up to the fifth round, when samples were analyzed from module 5 to 1. The cycle was repeated twice.
The evaluation of imprecision was carried out by comparison with analytical performance specifications for imprecision (CV APS ) of CPD parameters, as described elsewhere by Buoro et al. (14) .
Verification of analyzers harmonization
Venous blood samples were drawn from 30 apparently healthy blood donors (30-HBD) in K 3 EDTA tubes in three different days (i.e., 10 samples per day over one month; November 2015), and then analyzed within 30 minutes from collection on each of the five XN-modules. The inclusion criteria for these reference subjects were also based on a negative clinical history and normal serum concentrations of glucose, creatinine, aminotransferases, ferritin and C reactive protein.
The so-called Moving Average (MA) was assessed using all normal routine samples analyzed in the local laboratory over one month (i.e., November 2015). The inclusion criteria were as follows: absence of morphological flags, WBC count 4.0-10.0× 10 9 /L, hemoglobin 120-170 g/L, mean corpuscular volume (MCV) 84-98 fL, platelet count 150-450× 10 9 /L, red blood cell (RBC) distribution width (RDW-CV) <14.0%, nucleated RBCs (NRBCs) <0.01× 10 9 /L, NE count 2.00-5.60×10 9 /L, LY count 1.50-3.50×10 9 /L, MO count 0.30-0.80×10 9 /L, eosinophil count 0.10-0.60×10 9 /L and basophil count <0.20× 10 9 /L. According to these criteria, we finally selected 6,702 out of a total number of 35,500 routine samples (18.9%) received in the laboratory during the 1-month period. The daily results of normal level of the control material e-CHECK (XN-Check; Sysmex, Kobe, Japan) were also included in the evaluation. XN-Check was repeated for 40 days, for a total of 40 measurements on each of the five XN-modules. The median values of the CPD parameters obtained on each of the five XN-modules of samples were then compared. The overall harmonization of CPD parameters was finally assessed by calculating the percentage bias (Bias%) between the median value of results of each XN-module and the median value of combined results obtained with all the five XN-modules.
Due to the lack of internal and external quality controls for CPD parameters, we used the Overall Median (OMV) of each parameter as the reference value. The calculation of percentage difference between CPD parameters on each XN-Module was assessed using the formula [(median XN-Module -OMV) / (Median XN-Module + OMV)/2)]*100, as suggested by Fraser et al. (15) . The percent differences (Bias%) were then compared to the analytical performance specification for Bias % (B APS %) reported elsewhere (14) , whilst alignment bias based on intra-individual biological variation (B ALG %) was calculated according to , using the formula 0.33*CV I . The CV I s were obtained from data earlier published by Buoro et al. (14) . Difference significance of Bias%, and between B APS and B ALG , was assessed by estimating the overlap of 95% confidence interval (CI).
The distribution of data was tested with Shapiro and Wilk test (19) . Results were compared with Kruskal-Wallis test and one-way analysis of variance (ANOVA).
Both MA, 30-HBD samples and XN-Check control blood assessment were repeated after two months (January 2016). The possibility of introducing an instrumental alignment factor (IAF) was tested, as follows: overall mean/mean value of XN-module.
Assessment of blood sample stability
Ten ostensibly healthy, adult, Caucasian volunteers (5 women and 5 men; mean age 37±1 years and 35±2 years, respectively) were included in this part of the study. The inclusion criteria were again based on negative clinical history and normal serum concentrations of glucose, creatinine, aminotransferases, ferritin and C reactive protein. Venous blood samples (six samples for each subject) were drawn from an antecubital vein into K 3 EDTA evacuated blood tubes. The samples were analyzed 15-30 min after the venipuncture (T0). Three tubes were stored at Room Temperature (RT), whilst the remaining three tubes drawn from each subject were aliquoted and kept refrigerated at +4 °C. With the aim of studying the effect of storage time, each sample was then repeatedly measured after 4 hours (T4), 6 hours (T6), 8 hours (T8), 24 hours (T24), 36 hours (T36), up to 48 hours (T48) from collection, respectively. All measurements were performed in duplicate.
The differences between the various parameters measured in the paired aliquots were then assessed with Steel-Dwass-Critchlow-Fligner test (20) (21) (22) , with evaluation of Hodges-Lehmann location shift for multiple comparisons among different groups, after verification of values distribution with Shapiro-Wilk test. P-values < 0.05 were considered statistically significant. The results were finally reported as X (Tx-T0) in absolute value.
Percentage variations from the baseline result (T0) in samples with statistically significant differences were then analyzed with Bland-Altman plots (B%) and compared to B APS % (14) . The Bias% was also compared with the respective reference change values (RCV) (14) .
Statistical analysis
The statistical analysis was performed using Analyse-it™ software, version 3.90.5 (Analyse-it software Ltd; Leeds, UK). The study was approved by the ethical committee of the Papa Giovanni XXIII Hospital and was carried out in accordance with the Declaration of Helsinki under the terms of all relevant local legislation.
Results
Within-run imprecision
The results of within-run imprecision (expressed as coefficient of variation; CV) are shown in Table I . The imprecision of NE-parameters was 0.4-5.5%, whilst that of LY-parameters was 0.7-8.7%. Re markable variability was noticed in the within-run imprecision of MO-parameters across the five XN-modules, being 0.8-14.1%. Acceptable performance compared with the desirable analytical specification for imprecision derived from biological variation data published by Buoro et al. (14) was only met for NE-SFL and LY-Y across the five XN-modules. Although all CPD parameters reflecting cellular dispersion did not even fulfill the minimum target of analytical imprecision, the other parameters achieved this target in most XN-modules.
Analyzers harmonization
The mean values of the CPD parameters obtained in each group of samples are shown in Tables II, III, IV and Figures 1, 2 and 3 . Albeit a good agreement was found among the different XN-modules (maximum 4.0% Bias, except for NE, LY and MO-WZ), the median values were significantly different using both Kruskal-Wallis test and ANOVA, except for NE-WX, LY-WY, MO-WY.
The alignment was also assessed using intraindividual biological variation data (i.e., CV I ). The MO-WY parameter displayed a Bias% lower than the B ALG % obtained from biological variation (0.33*CV I ) (15) in all XN-Modules (Table II, III, IV) . The comparison between the target B ALG % and B APS % (14) showed a significant difference (i.e., lack of overlap between 95% CIs) for only the NE-SSC, NE-FCS, NE-WX, LY-WX and LY-WY parameters.
Notably, the median values of the CPD-parameters were not significantly different between the group of 30 healthy blood donors and the MA population. Nevertheless, the relative B% recorded for each XNmodule using control blood (i.e., containing stabilized cells) was found to be similar to that observed using fresh blood (i.e., obtained from the 30 healthy blood donors and the MA population). The median values of the CPD parameters were found to be similar to those obtained in a subsequent study, which was repeated two months later using additional fresh blood from 30 healthy blood donors and the MA population. These data attest that CPD-parameters may be quite stable over time.
The IAF was then calculated for each CPD parameter, and for each of the five XN-modules. When all CPD data were adjusted for the instrumentspecific IAF calculated from the MA population, the mean values were no longer statistically different among the five XN-modules, as shown in Figures 1, 2 and 3. In this case, the Bias% of all parameters for each XN-module was found to be lower than the B ALG % .
Data adjustment for instrument-specific IAF calculated from the results obtained on blood collected from 30 healthy blood donors confirmed the data, thus obtaining the same effective harmonization (data not shown). Identical results were obtained when the identical study was repeated two months afterward, thus suggesting that IAF should only be calculated on data generated from an MA population.
Assessment of blood sample stability
The different CPD-parameters displayed heterogeneous stability, mostly depending on the storage temperature (Table VI) . Overall, lower stability was observed in samples stored at 4 °C. More specifically, 2 hours storage at 4 °C was already sufficient to impair the assessment of NE-FSC, NE-WX and MO-X, whilst NE-SSC, NE-SFL, NE-WY, LY-Y, LY-WY, MO-Z and MO-WY were found to be stable for at least 8 hours, regardless of the storage temperature. Sample storage at 4 °C for 2 hours generated a B% higher than the analytical performance specification for Bias (B APS ) (14) for all parameters except NE-SFL, LY-Y, LY-WY, and MO-WY. Nevertheless, the %B of all para meters remained always lower than the RCV in all samples stored for up to 8 hours at both storage temperatures. Table I Within-run imprecision CPD parameters: the mean value (ch) and %CV, obtained from 10 replicates of five aliquots of a healthy subject, are shown and compared CV APS (14) .
Legend: CV APS : analytical performance specification for imprecision for desirable level; highlighted in grey: the imprecision does not meet the analytical goal for minimum performance. a) Median value NE-SSC before application of instrumental alignment factor; b) median value NE-SFL before application of instrumental alignment factor; c) median value NE-FCS before application of instrumental alignment factor; d) median value NE-SSC after application of instrumental alignment factor; e) median value NE-SFL after application of instrumental alignment factor; f) median value NE-FCS after application of instrumental alignment factor. 
Discussion
The aim of the study was to assess the current degree of CPD harmonization, using five separate Sysmex XN-modules allocated to the same clinical laboratory. Regarding the imprecision of the separate modules, only NE-SFC and LY-Y fulfilled the established specifications for desirable imprecision (14) . Other CPD parameters only met the minimum acceptable level of imprecision, whilst those reflecting cellular dispersion (i.e., NE, LY and MO-WX, WY and WZ) displayed unacceptable imprecision. This important finding should hence persuade the manufacturer to plan additional efforts for improving the current analytical performance.
The study design for verification of instrumental alignment was critical. Our study included five XNmodules, but specific control material with target values is not available. For this reason, we decided to use the OMV obtained for each parameter as the reference value. Our results confirm that comparing the Bias% of each XN-Module to B APS % may lead to incorrect assumptions, thus failing to detect a lack of instrumentation alignment. Conversely, the use of B AGL % seems much more appropriate for identifying poor instrumental alignment, as predictable. Therefore, data generated after the application of IAF correction attests that this harmonization approach may more effectively improve the alignment of CPD param eters among different XN modules.
According to our data, the performance of CPD parameters seems stable over time and, even more importantly, we could demonstrate that the use of data generated from normal routine samples (i.e., the MA population) may be reliably used as an inexpensive approach to improve harmonization of CPD parameters among separate XN-modules allocated in the same laboratory. The approach of calculating IAF is not new to the field of laboratory medicine, since it is successfully used for improving the harmonization of coagulation testing among separate analyzers using the identical reagents (i.e., adopting the socalled instrument specific international sensitivity index; ISI) (23) . Notably, once the XN-Check is certified for monitoring the analytical performance of CPD parameters, this control material may then be used for daily internal quality control assessment, for eventually highlighting the need for recalibration and thus ultimately improving inter-laboratory comparability.
Regarding the stability of whole blood samples at different temperatures, the data obtained in this study are quite comparable, and all CPD parameters seem more stable when maintained at room temperature for up to 2-4 hours. Interestingly, samples were found to be more stable at room temperature than at 496 Buoro et al.: Assessment of cell population data by XN-modules a) Median value MO-X before application of instrumental alignment factor; b) median value MO-Y before application of instrumental alignment factor; c) median value MO-Z before application of instrumental alignment factor; d) median value MO-X after application of instrumental alignment factor; e) median value MO-Y after application of instrumental alignment factor; f) median value MO-Z after application of instrumental alignment factor. 4°C, and this is probably due to the unfavorable effect of low temperatures on leukocyte physiology (24) . When the B% from results obtained immediately after collection (T0) was compared to the RCV, results were seemingly acceptable for at least 8 hours for all the CPD parameters, regardless of storage temperature. This is probably satisfactory, especially for samples collected from peripheral phlebotomy facilities which are then shipped for being analyzed in central or reference laboratories.
Conclusions
In conclusion, we found acceptable imprecision of all CPD parameters, except for those reflecting the dispersion of cellular clusters. Therefore, it seems now advisable to use only those parameters meeting the minimum analytical quality requirements in routine clinical practice, whilst the other parameters still need improvement of analytical performance before being widely used. Due to the lack of reference quality control materials, we also showed that the use of results generated on a large number of normal routine samples (i.e., the MA population) may be a reliable approach for checking between-instrument harmonization of CPD-parameters, by calculation of instrument-specific IAF. Nevertheless, the availability of both calibration and quality control materials for these parameters is highly advisable in the future, since traceable standards may allow further improvements in the process of widespread harmonization of CPD parameters. Finally we showed that whole blood samples may be stable for up to 2-4 hours for analysis of the vast majority of CPD parameters.
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